Patents by Inventor Elizabeth C. Hsia

Elizabeth C. Hsia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS
    Publication number: 20220324959
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies or antigen binding fragments thereof in a treatment of active Ankylosing Spondylitis (AS), e.g., a treatment utilizing the anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37.
    Type: Application
    Filed: May 11, 2020
    Publication date: October 13, 2022
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • ANTI-TNF ANTIBODY COMPOSITIONS, AND METHODS FOR THE TREATMENT OF PSORIATIC ARTHRITIS
    Publication number: 20220323580
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies or antigen binding fragments thereof in a treatment for active Psoriatic Arthritis (PsA), e.g., a treatment utilizing the anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37.
    Type: Application
    Filed: May 11, 2020
    Publication date: October 13, 2022
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Method of Treating Psoriatic Arthritis Patients with Inadequate Response to TNF Therapy with Anti-IL23 Specific Antibody
    Publication number: 20220289834
    Abstract: A method of treating psoriatic arthritis in a patient having showed an inadequate response to treatment with an anti-TNF therapy by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically proven effective amount and the patient achieves significant ACR20/50/70, IGA, HAQ-DI, CRP, SF-36 PCS/MCS, MDA, VLDA, enthesitis, dactylitis, and LEI/dactylitis improvement as measured 16, 24 and 48 weeks after initial treatment.
    Type: Application
    Filed: March 10, 2022
    Publication date: September 15, 2022
    Inventors: Elizabeth C. Hsia, Chetan Karyekar, Alexa Kollmeier, Wim Noel, Jaime Oliver Vigueras, Agata Schubert-Wlodarczyk, May Shawi, Virginia Taliadouros, Elke Theander, Xie Xu
  • Anti-TNF Antibodies, Compositions, and Methods for the Treatment of Active Ankylosing Spondylitis
    Publication number: 20220195028
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies or antigen binding fragments thereof in a treatment of active Ankylosing Spondylitis (AS), e.g., a treatment utilizing the anti-TNF antibody having heavy chain complementarity-determining region (CDR) amino acid sequences SEQ ID NOS:40-42 and light chain CDR amino acid sequences SEQ ID NOS:43-45.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 23, 2022
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Anti-TNF Antibody Compositions for Use in Methods for the Treatment of Psoriatic Arthritis
    Publication number: 20220064278
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 in a treatment for active Psoriatic Arthritis (PsA).
    Type: Application
    Filed: January 14, 2020
    Publication date: March 3, 2022
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Method for treating pre-type 1 diabetes in a human subject
    Patent number: 11124565
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: September 21, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS
    Publication number: 20210277104
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Psoriatic Arthritis (PsA).
    Type: Application
    Filed: May 14, 2021
    Publication date: September 9, 2021
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS
    Publication number: 20210238271
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Application
    Filed: April 22, 2021
    Publication date: August 5, 2021
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Methods for the treatment of active Psoriatic Arthritis
    Patent number: 11041020
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Psoriatic Arthritis (PsA).
    Type: Grant
    Filed: July 20, 2019
    Date of Patent: June 22, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Anti-TNF antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
    Patent number: 11014982
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Grant
    Filed: July 20, 2019
    Date of Patent: May 25, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
    Publication number: 20190375836
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Application
    Filed: August 14, 2019
    Publication date: December 12, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS
    Publication number: 20190345244
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Application
    Filed: July 20, 2019
    Publication date: November 14, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS
    Publication number: 20190338022
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Psoriatic Arthritis (PsA).
    Type: Application
    Filed: July 20, 2019
    Publication date: November 7, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
    Patent number: 10465003
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: November 5, 2019
    Assignee: Janssen Biotech, Inc.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
    Publication number: 20190092849
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Application
    Filed: February 2, 2017
    Publication date: March 28, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS
    Publication number: 20180222972
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Ankylosing Spondylitis (AS).
    Type: Application
    Filed: November 20, 2017
    Publication date: August 9, 2018
    Applicant: Janssen Biotech, Inc.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS
    Publication number: 20180215819
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the safe and effective treatment of active Psoriatic Arthritis (PsA).
    Type: Application
    Filed: November 20, 2017
    Publication date: August 2, 2018
    Applicant: Janssen Biotech, Inc.
    Inventors: Diane D. Harrison, Elizabeth C. Hsia, Lee-Lian Kim, Kim Hung Lo
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
    Publication number: 20170247444
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Application
    Filed: February 1, 2017
    Publication date: August 31, 2017
    Applicant: Janssen Biotech, Inc.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka